@oiinfusion Profile picture

OI Infusion Services

@oiinfusion

Turnkey in-office infusion center management helping you grow your practice and provide better patient care.

Joined July 2018
Similar User
OLA OF LAGOS (Motivator 🦹🏾‍♂️🦸🏿‍♂️) photo

@OlamideOlaleke3

Jabawaki 🌐 photo

@cordova_d22

Gbenga Afuape photo

@ggola1800

InfusionMed USA photo

@InfusionMedUSA

PainWarriorPrincess / Pain Warrior USA photo

@PainWarriorUSA

Claude Savage photo

@ClaudeSavage12

The FDA made a landmark decision to approve Aducanumab for the treatment of Alzheimer's. Is your practice prepared to offer this treatment to your patients? If not, please reach out... hubs.ly/H0PKV2f0


COVID-19 Vaccine Allocation: Ethical Concerns, Practical Challenges hubs.ly/H0zmbwR0


Pfizer CEO Rules Out Vaccine Announcement Before Election Day hubs.ly/H0yW_Hl0


Why Gastroenterologists Should Offer In-Office Infusions hubs.ly/H0yj_wP0


Global Handwashing Day: It's more important than ever hubs.ly/H0y2mwp0


OI Infusion's Instagram page is live! Follow along where we will share #infusionnews and more! hubs.ly/H0xF5920


Tips for Full-Time Working Parents Managing Remote Learning During Covid hubs.ly/H0w-2LC0


Rheumatologists Face Challenges in Identifying High-Quality COVID-19 Literature - Rheumatology Advisor hubs.ly/H0vSG_B0 by @RheumAdvisor


Rheumatologists Face Challenges in Identifying High-Quality COVID-19 Literature - Rheumatology Advisor hubs.ly/H0vp-nz0 by @RheumAdvisor


If Approved, Is Your Practice Prepared to Infuse Aducanumab? hubs.ly/H0v04T_0


Pfizer Announces Agreement with Gilead to Manufacture Remdesivir for Treatment of COVID-19 | Pfizer hubs.ly/H0tMsm50


FDA Accepts Aducanumab for Review as Alzheimer Disease Treatment hubs.ly/H0tMyDF0


Can SARS-CoV-2 Infection Accelerate the Onset of an Autoimmune Disease? - Rheumatology Advisor hubs.ly/H0tvRzX0


Considerations for Opening an Infusion Center During Covid-19 hubs.ly/H0tvYDh0


Advice For The Newly Diagnosed - National Infusion Center Association hubs.ly/H0sTXtp0


Loading...

Something went wrong.


Something went wrong.